Clinical Trial Update: Circulating Cell-free DNA-based Epigenetic Biomarker MSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis [NA]

View source ↗

Summary

This clinical trial update reports on using circulating cell-free DNA methylation biomarker MSEPT9 to detect hepatocellular carcinoma in patients with cirrhosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatocellular Carcinoma

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Hepatocellular Carcinoma, Cirrhosis | NA | Status: COMPLETED